Agenus (AGEN) Total Current Liabilities (2010 - 2026)
Agenus' (AGEN) quarterly Total Current Liabilities came in at $249.2 million in Q1 2026, up 19.65% year-on-year from $208.3 million in Q1 2025, and down 22.95% quarter-over-quarter from $323.5 million in Q4 2025.
Agenus (AGEN) Total Current Liabilities (2010 - 2026) Analysis & Trends
Agenus' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $249.2 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 19.65% year-over-year to $249.2 million in Q1 2026; TTM through Mar 2026 was $249.2 million, a 19.65% increase from a year earlier, with the FY2025 full-year figure at $323.5 million, up 46.11% from the prior year.
- Total Current Liabilities fell to $249.2 million in Q1 2026 per AGEN's latest filing, from $323.5 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $323.5 million in Q4 2025 and bottomed at $645000.0 in Q3 2025.
- The 5-year median for Total Current Liabilities is $190.9 million (2023), against an average of $157.9 million.
- Across the five-year window, Total Current Liabilities jumped 7922.11% in 2024 and tumbled 98.85% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $3.5 million in 2022, then jumped by 7200.91% to $255.9 million in 2023, then declined by 13.48% to $221.4 million in 2024, then jumped by 46.11% to $323.5 million in 2025, then fell by 22.95% to $249.2 million in 2026.
- Per Business Quant, the three latest AGEN Total Current Liabilities figures stand at $249.2 million (Q1 2026), $323.5 million (Q4 2025), and $645000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | 249.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 249.24 Mn |
| Dec 31, 2025 | 323.49 Mn |
| Sep 30, 2025 | 645,000.00 |
| Jun 30, 2025 | 3.13 Mn |
| Mar 31, 2025 | 208.30 Mn |
| Dec 31, 2024 | 221.40 Mn |
| Sep 30, 2024 | 3.01 Mn |
| Jun 30, 2024 | 270.67 Mn |
| Mar 31, 2024 | 256.00 Mn |
| Dec 31, 2023 | 255.90 Mn |
| Sep 30, 2023 | 198.36 Mn |
| Jun 30, 2023 | 3.37 Mn |
| Mar 31, 2023 | 190.90 Mn |
| Dec 31, 2022 | 3.51 Mn |
| Sep 30, 2022 | 173.07 Mn |
| Jun 30, 2022 | 159.72 Mn |
| Mar 31, 2022 | 163.06 Mn |
| Dec 31, 2021 | 156.94 Mn |
| Sep 30, 2021 | 150.13 Mn |
| Jun 30, 2021 | 168.75 Mn |